The Market Aktie 130912141 / AU0000306037
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
|
09.10.2025 22:48:03
|
Why Akero Therapeutics Stock Trounced the Market on Thursday
One of the best catalysts for sudden, sharp rise in the price of a stock is when the company behind it get acquired at a premium. Case in point: Akero Therapeutics (NASDAQ: AKRO), whose shares soared by more than 16% Thursday after it was revealed the biotech will have a new owner. That pop was especially impressive, given that the bellwether S&P 500 (SNPINDEX: ^GSPC) slumped by 0.3% on the day.Akero's buyer is none other than Novo Nordisk, the Denmark-based pharmaceutical company behind star weight loss drug Wegovy. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool